UPDATE 2-Inspire Pharma Eye Drug Fails In Late-Stage Trial

Friday, January 22, 2010

Comments

Reuters

Inspire Pharmaceuticals Inc (ISPH.O) said its experimental drug, Prolacria, for the treatment of dry eye disease failed to meet the main goal in a late-stage trial, sending the company's shares down as much as 20 percent.

Full Story

Refractive Products and Equipment »

The clinical picture is consistent with which diagnosis?
1. Moorens ulcer
2. Cystinosis
3. Terriens Marginal Degeneration
4. Keratoconus
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

UPDATE 2-Inspire Pharma Eye Drug Fails In Late-Stage Trial

Comments

Related Categories

Refractive Products and Equipment »

Quick Quiz

The clinical picture is consistent with which diagnosis?

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

VISUPLAN 500 Non-Contact Tonometer

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us